ImmuCell Corp (ICCC)
5.05
0.00 (0.00%)
USD |
NASDAQ |
Apr 17, 15:49
ImmuCell SG&A Expense (Quarterly): 1.195M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.195M |
September 30, 2023 | 1.332M |
June 30, 2023 | 1.249M |
March 31, 2023 | 1.446M |
December 31, 2022 | 1.576M |
September 30, 2022 | 1.193M |
June 30, 2022 | 1.188M |
March 31, 2022 | 1.497M |
December 31, 2021 | 1.326M |
September 30, 2021 | 1.100M |
June 30, 2021 | 0.8587M |
March 31, 2021 | 0.9457M |
December 31, 2020 | 1.085M |
September 30, 2020 | 0.8509M |
June 30, 2020 | 0.8879M |
March 31, 2020 | 1.065M |
December 31, 2019 | 1.108M |
September 30, 2019 | 0.8964M |
June 30, 2019 | 0.9757M |
March 31, 2019 | 1.026M |
December 31, 2018 | 1.059M |
September 30, 2018 | 0.8913M |
June 30, 2018 | 0.9184M |
March 31, 2018 | 0.955M |
December 31, 2017 | 0.8915M |
Date | Value |
---|---|
September 30, 2017 | 0.8324M |
June 30, 2017 | 0.7997M |
March 31, 2017 | 0.8941M |
December 31, 2016 | 0.8456M |
September 30, 2016 | 0.8464M |
June 30, 2016 | 0.838M |
March 31, 2016 | 0.7562M |
December 31, 2015 | 0.8649M |
September 30, 2015 | 0.6833M |
June 30, 2015 | 0.6448M |
March 31, 2015 | 0.7002M |
December 31, 2014 | 0.6809M |
September 30, 2014 | 0.6758M |
June 30, 2014 | 0.5765M |
March 31, 2014 | 0.5431M |
December 31, 2013 | 0.4926M |
September 30, 2013 | 0.4848M |
June 30, 2013 | 0.4881M |
March 31, 2013 | 0.4604M |
December 31, 2012 | 0.5034M |
September 30, 2012 | 0.4833M |
June 30, 2012 | 0.4214M |
March 31, 2012 | 0.4835M |
December 31, 2011 | 0.4446M |
September 30, 2011 | 0.4143M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.8509M
Minimum
Sep 2020
1.576M
Maximum
Dec 2022
1.146M
Average
1.108M
Median
Dec 2019
SG&A Expense (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 2.609M |
Palatin Technologies Inc | 3.033M |
iBio Inc | 2.961M |
Theriva Biologics Inc | 2.021M |
Ampio Pharmaceuticals Inc | 0.973M |